key: cord-0899299-5mh3ds6y authors: Laamarti, Meriem; Alouane, Tarek; Kartti, Souad; Chemao-Elfihri, M.W.; Hakmi, Mohammed; Essabbar, Abdelomunim; Laamarti, Mohamed; Hlali, Haitam; Allam, Loubna; El Hafidi, Naima; El Jaoudi, Rachid; Allali, Imane; Marchoudi, Nabila; Fekkak, Jamal; Benrahma, Houda; Nejjari, Chakib; Amzazi, Saaid; Belyamani, Lahcen; Ibrahimi, Azeddine title: Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations date: 2020-05-21 journal: bioRxiv DOI: 10.1101/2020.05.03.074567 sha: 110f4cc408c8ab07aa137ee65baf8044633e21be doc_id: 899299 cord_uid: 5mh3ds6y In late December 2019, an emerging viral infection COVID-19 was identified in Wuhan, China, and became a global pandemic. Characterization of the genetic variants of SARS-CoV-2 is crucial in following and evaluating it spread across countries. In this study, we collected and analyzed 3,067 SARS-CoV-2 genomes isolated from 55 countries during the first three months after the onset of this virus. Using comparative genomics analysis, we traced the profiles of the whole-genome mutations and compared the frequency of each mutation in the studied population. The accumulation of mutations during the epidemic period with their geographic locations was also monitored. The results showed 782 variant sites, of which 512 (65.47%) had a non-synonymous effect. Frequencies of mutated alleles revealed the presence of 38 recurrent non-synonymous mutations, including ten hotspot mutations with a prevalence higher than 0.10 in this population and distributed in six SARS-CoV-2 genes. The distribution of these recurrent mutations on the world map revealed certain genotypes specific to the geographic location. We also found co-occurring mutations resulting in the presence of several haplotypes. Moreover, evolution over time has shown a mechanism of mutation co-accumulation which might affect the severity and spread of the SARS-CoV-2. On the other hand, analysis of the selective pressure revealed the presence of negatively selected residues that could be taken into considerations as therapeutic targets We have also created an inclusive unified database (http://genoma.ma/covid-19/) that lists all of the genetic variants of the SARS-CoV-2 genomes found in this study with phylogeographic analysis around the world. We used Hyphy v2. 5.8 (13) to estimate synonymous and non-synonymous ratio dN / dS 126 (ω). Two datasets of 191 and 433 for orf1ab and genes respectively were retrieved from 127 Genbank (http://www.ncbi.nlm.nih.gov/genbank/). After deletion of duplicated and 128 cleaning the sequences, only 91 and 39 for orf1ab and spike proteins, respectively, were 129 used for the analysis (Additional file 1: Table S2 ). The selected nucleotide sequences of 130 each dataset were aligned using Clustalw codon-by-codon and the phylogenetic tree was Table S3 ). These proteomes were used for the construction of pangenome at the inter-148 specific scale of Betacoronavirus and intra-genomic of SARS-CoV-2. The strategy of best 149 reciprocal BLAST results (18) was implemented to identify all of the orthologous genes 150 using Proteinortho v6.0b (19) . Proteins with an identity above 60% and sequence coverage 151 above 75% with an e-value threshold below 1e-5 were used to be considered as significant 152 hits. 153 In this study, we used 3,067 SARS-CoV2 complete genomes collected from GISAID 157 EpiCovTM (update: 02-04-2020) and NCBI (update: 20-03-2020) databases. These strains 158 were isolated from 55 countries (Fig 1A) . The most represented origin was American 159 strains with 783 (25.53%), followed by strains from England, Iceland, and China with 407 160 (13.27%), 343 (11.18%), 329 (10.73%), respectively. The date of isolation was during the 161 first three months after the appearance of the SARS-CoV-2 virus, from December 24, 2019, 162 to March 25, 2020 (Fig 1B) . Likewise, about two-thirds of these strains collected in this 163 work were isolated during March. 164 To study and follow the appearance and accumulation of mutations, we have traced the 166 profiles of these mutations and compared their frequencies in the population studied. 167 Remarkably, compared to the Wuhan-Hu-1/2019 reference sequence, a total of 782 variant 168 sites were identified, including 512 (65.47%) non-synonymous mutations, 222 (28.38%) 169 synonymous mutations, and four (0.51% ) deletion mutation effect. The rest (5.64%) 170 distributed to the intergenic regions. Frequency analysis of the mutated alleles revealed the 171 presence of 68 recurrent mutations with a prevalence greater than 0.006 (0.06% of the 172 population), which corresponds to at least 20 / 3,067 genomes of SARS-CoV-2. Focusing 173 on recurrent non-synonymous mutations, 38 was found and distributed in six genes with 174 variable frequencies (Fig 2) , of which the gene coding for replicase polyprotein (orf1ab), 175 spike protein, membrane glycoprotein, nucleocapsid phosphoprotein, ORF3a, and ORF8. 176 Overall, orf1ab harbored more non-synonymous mutations compared to the other five 177 genes with 22 mutations, including three mutations located in nsp12-RNA-dependent 178 RNA polymerase (RdRp) (M4555T, T4847I and T5020I), three in nsp13-helicase 179 (V5661A, P5703L and M5865V), two in nsp5-main proteinase (G3278S and K3353R), 180 two in nsp15-EndoRNAse (I6525T, Ter6668W), two in nsp3-multi domains (A876T and 181 T1246I), one in nsp14-exonuclease (S5932F) and one in nsp4-transmembrane domain 2 182 (F3071Y). Likewise, spike protein harbored three frequent mutations, including V483A in 183 receptor-binding domain (RBD). The rest of the mutations were found in nucleocapsid S194L, S197L, S202N, R203K and G204R), membrane glycoprotein (D3G and T175M) 186 and ORF8 (V62L and L84S). 187 Interestingly, among all recurrent mutations, ten were found as hotspot mutations with a 189 frequency greater than 0.10 in this study population (Fig 2) and 229 (29%) singleton mutations specific to China and USA genomes respectively, 203 followed by Malaysia and France with 3,6% and 2,4%, respectively. 204 It is interesting to note that among the 55 countries, 21 harbored singleton mutations. 205 (Additional file 3: Table S4 ) illustrates the detailed singleton mutations found in these 206 countries. The majority of the genomes analyzed carried more than one mutation. 207 However, among the recurrent non-synonymous, synonymous, deletion and intergenic 208 mutations, we found G251V (in ORF3a), and S5932F (in ORF1ab) present on all 209 continents except Africa (Fig 3) . While F924F, L4715L (in orf1ab), D614G (in spike) 210 appeared in all strains except those from Asia. In Algeria, the genomes harbored mutations 211 very similar to those in Europe, including two recurrent mutations T265I and Q57H of the 212 ORF3a. Likewise, the European and Dutch genomes also shared ten recurrent mutations are considered to be transition mutations with a high ratio of A substituted by G. 219 The genome variability was more visible in China and USA than in the rest of the world. 220 SARS-CoV-2 genomes also harbored three co-occurrent mutations R203K, R203R and 221 G204R in the N protein and were present in all continents except Africa and Asia (besides 222 Taiwan). 223 We selected the genomes of the SARS-CoV-2 virus during the first three months after the 225 emergence of this virus (December 24 to March 25). We have noticed that the mutations 226 have accumulated at a relatively constant rate (Fig 4) . The strains selected at the end of 227 The phylogenetic tree based on the whole genome alignment demonstrates that SARS-242 CoV-2 is wildly disseminated across distinct geographical location. The results showed 243 that several strains are closely related even though they belong to different countries. 244 For phylogenetic tree (http://genoma.ma/covid-19/) showed multiple introduction dates of 246 the virus inside the USA with the first haplotype introduced related to the second epidemic 247 wave in China. 248 Using correlation analysis between most recurrent mutations and countries distribution 249 (Fig 5) . We observed that most recurrent mutations clusters could be divided into four 250 groups; the bigger cluster compromised nine mutations from the ten hotspots, while the 251 first cluster harbored only the orf1ab mutation L3606F. 252 Meanwhile, geo clustering by geographic location showed two distinct clusters (Fig 5) , 253 cluster A grouping countries from Europe with those from America and Africa. However, 254 The modelling results of orf1ab showed that the sites with positive selections were 277 distributed in nsp3 and nsp4, while the negatively selected codons were located in nsp3, 278 nsp4, nsp6, nsp12, nsp13, nsp14 and nsp16 (Fig 6) . In spike, the only negatively selected 279 residue was observed in the RBD region (Fig 7) . 280 In order to highlight the structural proteins shared at the inter-specific scale between the Table S3 ), of which ten proteins cluster were shared between SARS-CoV-2 and only three 288 species of the genus Betacoronavirus (BatCoV RaTG13, SARS-CoV and Bat Hp-289 betacoronavirus/ Zhejiang2013). Of these, BatCoV RaTG13 had more orthologous 290 proteins shared with SARS-CoV-2, followed by SARS-CoV with ten and nine orthologous 291 proteins, respectively (Fig 8A) . It is interesting to note that among all the strains used of 292 Betacoronavirus, the ORF8 protein was found in orthology only between SARS-RATG13 293 and SARS-CoV-2. In addition, the ORF10 protein was found as a singleton for SARS-294 On the other hand, the analysis of the pangenome at the intra-genomic scale of 83 isolates 296 of SARS-CoV-2 (Fig 8B) , showed that ORF7b and ORF10 were two accessory proteins 297 (proteins variable) in SARS-CoV-2 genomes, while the other proteins belonged to the core 298 proteins of SARS-CoV-2 (conserved in all genomes). 299 The rate of mutations results in viral evolution and variability in the genome, thus allowing 301 viruses to escape host immunity, as well as drugs (20). Initial published data suggests that 302 SARS-CoV-2 is genetically stable (21) which may increase the effectiveness of vaccines 303 under development. The study on the genomic variation of SARS-CoV-2 is very of SARS-CoV-2 infection. In this study, we characterized the genetic variations in a large 306 population of SARS-CoV-2 genomes. Our results showed a diversity of mutations detected 307 with different frequencies. Overall, more than 500 non-synonymous mutations in SARS-308 CoV-2 genomes have been identified. The orf1ab gene having more than half the size of 309 the SARS-CoV-2 genome and is divided into 16 nsp (nsp1-nsp16) (22). We found more 310 than half of recurrent mutations in orf1ab, and a high mutation rate in nsp3, nsp12 and 311 nsp2, with 124, 57 and 46, respectively. Nsp2 and nsp3 were both essential for correcting 312 viral replication errors (23). Thus, recent studies have suggested that mutations falling in 313 the endosome -associated -protein -like domain of the nsp2, could explain why this virus 314 is more contagious than SARS (24). 315 The replication enzymes nsp12 to nsp16 have been reported as antiviral targets for SARS-316 CoV (25). In the SARS-CoV-2 genomes, we found that nsp12 to nsp15 harbored nine 317 The authors declare that they have no competing interests. 395 We sincerely thank the authors and laboratories around the world who have sequenced and 397 shared the full genome data for SARS-CoV-2 in the GISAID database. All data authors 398 can be contacted directly via www.gisaid.org. D e c -2 3 -J a n -0 1 J a n -0 2 -J a n -1 1 J a n -1 2 -J a n -2 1 J a n -2 2 -J a n -3 V378I G392D H417R I739V A876T T1246I F3071Y G3278S K3353R L3606F M4555T T4847I T5020I V5661A S5932F I6525T Ter6668W V483A D614G P1263L Q57H H93Y G196V G251V D3G T175M V62L L84S S193I S194L S197L S202N R203K V378I G392D H417R I739V A876T T1246I F3071Y G3278S K3353R L3606F M4555T T4847I T5020I V5661A S5932F I6525T Ter6668W V483A D614G P1263L Q57H H93Y G196V G251V D3G T175M V62L L84S S193I S194L S197L S202N R203K T723T N824N G1044G P1263L Q57H H93Y G196V G251V D3G A69A Y71Y T175M D61D V62L L84S D128D orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab orf1ab D448del L6669L L16L H83H T265I V378I G392D H417R Y717Y I739V P765S A876T F924F T1246I S2839S H2986H Infection prevention and control during health care 405 when COVID-19 is suspected: interim guidance Coronaviridae. In: Virus taxonomy. Classification and nomemclature 410 of viruses Coronavirus host divergence and novel coronavirus 415 (Sars-CoV-2) outbreak. Clinical and Experimental Ocular Trauma and 416 Infection The proximal 418 origin of SARS-CoV-2 A new coronavirus 421 associated with human respiratory disease in China patients' clinical characteristics, discharge rate, and fatality rate of meta-426 analysis Minimap2: pairwise alignment for nucleotide sequences A program 433 for annotating and predicting the effects of single nucleotide polymorphisms SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118 MUSCLE: multiple sequence alignment with high accuracy and 437 high throughput ClustVis: A web tool for visualizing clustering of 440 multivariate data using Principal Component Analysis and heatmap HyPhy: hypothesis testing using phylogenies Evolutionary Genetics Analysis across Computing Platforms Not so different after all: a comparison of methods for 448 detecting amino-acid sites under selection Fubar: 451 a fast, unconstrained Bayesian approximation for inferring selection Individual Sites Subject to Episodic Diversifying Selection Essential genes are more 457 evolutionarily conserved than are nonessential genes in bacteria Proteinortho: detection of (Co-)orthologs in large-scale analysis Emerging SARS-CoV-2 Mutation Hot Spots Include a Novel RNA-dependent Discovery 467 of a 382-nt deletion during the early evolution of SARS-CoV-2. BioRxiv 468 Genomic characterization of a novel 471 SARS-CoV-2 Identification of severe acute respiratory syndrome 475 coronavirus replicase products and characterization of papain-like protease 476 activity COVID 2019: the role of the nsp2 and nsp3 in its pathogenesis Structural view of selective pressure in spike gene. The negatively selected 626 site in spike protein is highlighted in red. The only amino acid residue selected negatively 627 on the receptor-binding domain corresponds to GLN-474. The cryo-EM structure with 628 PDB id 6VSB was used as a model for the gene